pharmaphorum

FEBRUARY 3, 2021

Nazzi joins Almirall as the Barcelona-based specialist in dermatological therapies is rolling out a series of new drugs that it thinks can collectively add more than €1 billion to its revenues in the coming years – a big increase considering it made just over €620 million in the first nine months of 2020.

Dermatology 52

Dermatology Marketing Branding Medicine 52

Pharma Marketing Network

MARCH 3, 2025

But how can pharma brands optimize their digital assets while staying compliant with industry regulations? Brands spend millions on programmatic advertising and SEO to drive traffic, but what happens when HCPs and patients visit your site and dont take action? Imagine a pharma website as a digital waiting room.

Branding 52

Branding Compliance Marketing Dermatology 52

XTalks

JUNE 17, 2024

This is a huge achievement for Hugel as we focus on becoming a top aesthetics brand in the US,” said James Hartman, president of Hugel America in the news release. “As “We are thrilled with the FDA’s approval of Letybo. 134 How Does Letybo Work?

FDA Approval 52

FDA Approval Marketing Botox Clinical Trials 52

Druggist

DECEMBER 9, 2020

Clobetasone (brand name: Eumovate cream). Clobetasone (brand name: Eumovate) is the second steroid cream on the list, which is available over the counter. Best selling bite and sting brand Triple action against pain, itching and inflammation Relief from insect bites, insect stings and stinging nettles. Antihistamine creams.

Pharmacy 97

Pharmacy Containment Sales Production 97

XTalks

DECEMBER 15, 2020

In the deal, Synteract’s brand will remain intact but it will operate as a Syneos Health Business Unit, continued to be led by a strong management team that includes current Synteract President Steve Powell.

Dermatology 52

Dermatology Clinical Trials Clinical Trials Branding 52

pharmaphorum

SEPTEMBER 29, 2022

Dupixent (dupilumab) has been approved on the back of two phase 3 trials in patients with prurigo nodularis whose symptoms were inadequately controlled with current drugs. The suffering he notes from the #itch is 100… [link]. — Brian S. Kim (@itchdoctor) September 29, 2022.

Drugs 69

Drugs Immune Response Allergies Sales 69

XTalks

DECEMBER 20, 2023

The companies include a diverse range engaged in innovative approaches in areas like oncology, genetic medicines, inflammatory diseases, dermatology and cardiorenal therapy. report indicating that they accounted for half of the most viewed new brands. Notably, pharmaceutical drugs dominated TV ad impressions this year, with an iSpot.tv

Life Science 59

Life Science Clinical Trials Clinical Trials FDA Approval 59

pharmaphorum

OCTOBER 28, 2020

Sanofi sees plenty of additional upside, suggesting the drug could become a $10 billion brand at peak from expansion in atopic dermatitis as well as new indications like asthma, chronic rhinosinusitis with nasal polyps and eosinophilic oesophagitis. The partners plan to file for approval of Olumiant in the US and Japan this year.

Drugs 52

Drugs Sales Marketing FDA Approval 52

Delveinsight

AUGUST 25, 2021

Pharmaceutical companies may deal in both generic and brand-name drugs as well as medical devices. The Innovative Medicines Division focuses on Oncology, Immunology, Hepatology, Dermatology, Ophthalmology, Neuroscience, Cardiovascular, Renal and Metabolism, and Respiratory. The global healthcare spending in 2020 was USD 8.3

Vaccination 98

Vaccination Vaccine Drugs Sales 98

XTalks

DECEMBER 14, 2023

However, its uses expanded over the years into other indications, ranging from parasitic infection to dermatology. In 2000, it was approved in a topical form (under the brand name Vaniqa) for reducing excessive facial hair growth in women, a condition known as hirsutism.

FDA Approval 52

FDA Approval Dermatology Drugs DNA 52

pharmaphorum

APRIL 26, 2021

The IL-17A and IL-17F inhibitor hit all its objectives in the phase 2 trial, which has now been published in The Lancet, and showed that it was significantly more effective than placebo at clearing up skin lesions in patients with moderate to severe plaque psoriasis. billion in sales last year.

Antibody 52

Antibody Drugs Marketing Licensing 52

The Pharma Data

APRIL 26, 2021

COVID-19 negatively impacted demand, particularly: dermatology, ophthalmology, the breast cancer portfolio, Sandoz Retail and Anti-Infectives. Growth was offset by declines in Established Medicines and mature Ophthalmology brands. Adakveo sales reached USD 37 million. Tafinlar + Mekinist.

Sales 40

Sales Medicine Production Manufacturing 40

The Pharma Data

DECEMBER 15, 2020

Klisyri is the first FDA approved branded proprietary product for Athenex and will be launched in partnership with Almirall in the U.S. We invest in differentiated and groundbreaking medical dermatology products to bring our innovative solutions to patients in need. during the first quarter of 2021.

FDA Approval 52

FDA Approval Development Production Drugs 52

Delveinsight

AUGUST 13, 2020

Approval History: In September 2017, FF/UMEC/VI was approved in the US under the brand name Trelegy Ellipta for the long-term, once-daily maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). REGN3500 is being studied in Phase II trials for asthma, chronic obstructive pulmonary disease and atopic dermatitis.

Antibody 40

Antibody Medicine Trials Development 40

Pharma Marketing Network

OCTOBER 27, 2020

Robin also coaches people who want to become thought leaders to drive their marketing, personal branding and career advancements. As a speaker Robin has had over a hundred and forty speaking engagements in 13 countries and she’s the author of two books, The Patient as CEO and Thought Leader Formula.

Insulin 52

Insulin Marketing Doctor Doctors 52

Pharma Marketing Network

OCTOBER 27, 2020

Robin also coaches people who want to become thought leaders to drive their marketing, personal branding and career advancements. As a speaker Robin has had over a hundred and forty speaking engagements in 13 countries and she’s the author of two books, The Patient as CEO and Thought Leader Formula.

Insulin 52

Insulin Doctor Doctors Marketing 52

The Pharma Data

AUGUST 3, 2021

New-to-brand prescription (NBRx) volumes grew 10% year-over-year, even as patient visits to dermatologists remained 15% below pre-pandemic levels. We expect that recovery in the dermatology segment will continue to progress over the coming quarters. In the U.S., Otezla continued to maintain first-line share leadership in psoriasis.

Sales 52

Sales Production Antibody Development 52

Pharmaceutical Technology

JANUARY 25, 2023

Clinical trials require precision and faultless execution for hypotheses to become therapies. For most of pharmaceutical history, this has made the potential benefits from outsourcing elements of these trials elusive. The world of clinical trials is changing. Remote trials - remote possibility?

Clinical Trials 147

Clinical Trials Clinical Trials Trials Research 147

Pharmaceutical Technology

JANUARY 25, 2023

Clinical trials require precision and faultless execution for hypotheses to become therapies. For most of pharmaceutical history, this has made the potential benefits from outsourcing elements of these trials elusive. The world of clinical trials is changing. Remote trials - remote possibility?

Clinical Trials 130

Clinical Trials Clinical Trials Trials Research 130

Pharma Marketing Network

MARCH 19, 2025

But how can pharma brands create meaningful connections in a digital landscape crowded with content? It also builds trust and credibility through evidence-based content and transparent communication while increasing brand awareness by ensuring that the right audiences receive relevant information.

Marketing 52

Marketing Branding Compliance Cardiology 52